GUARDIAN | Science

New GLP-1 pill helps patients lose up to 8% of body weight, trial shows

新型GLP-1药丸帮助患者减轻多达8%的体重，试验显示

Orforglipron is not has not yet been approved by regulators in the UK, US or Europe.

2026-02-26 572词中等

字体

Orforglipron has not yet been approved by regulators in the UK, US or Europe, though the US Food and Drug Administration is reviewing it. At present, semaglutide is the only GLP-1 medication for type 2 diabetes available in pill form in the US.

请登录后继续阅读完整文章

还没有账号？立即注册

成为会员后您将享受无限制的阅读体验，并可使用更多功能，了解更多

免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。